
[09-23-2010] The U.S. Food and Drug Administration announced that it will significantly restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other medications. These new restrictions are in response to data that suggest an elevated risk of cardiovascular events, such as heart attack and stroke, in patients treated with Avandia.
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformation...
Permalink Reply by Brian (bsc) on September 30, 2010 at 10:06am
Permalink Reply by Brian (bsc) on September 30, 2010 at 11:37am
Permalink Reply by Billy on November 10, 2010 at 9:44am Manny Hernandez(Co-Founder, Editor, has LADA)
|
Bradford (has type 1) |
Lorraine (mother of type 1) |
Marie B (has type 1) |
|
|
|
|
|
|
This site complies with the HONcode standard for trustworthy health information: verify here.
© 2013 A community of people touched by diabetes, run by the Diabetes Hands Foundation.
